TNXP
Price
$39.86
Change
-$0.59 (-1.46%)
Updated
Jun 4, 01:59 PM (EDT)
Capitalization
296.28M
68 days until earnings call
TOVX
Price
$0.43
Change
-$0.04 (-8.51%)
Updated
Jun 4, 10:45 AM (EDT)
Capitalization
3.85M
Interact to see
Advertisement

TNXP vs TOVX

Header iconTNXP vs TOVX Comparison
Open Charts TNXP vs TOVXBanner chart's image
Tonix Pharmaceuticals Holding
Price$39.86
Change-$0.59 (-1.46%)
Volume$100
Capitalization296.28M
Theriva Biologics
Price$0.43
Change-$0.04 (-8.51%)
Volume$5.23K
Capitalization3.85M
TNXP vs TOVX Comparison Chart
Loading...
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TNXP vs. TOVX commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TNXP is a Hold and TOVX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (TNXP: $40.45 vs. TOVX: $0.47)
Brand notoriety: TNXP and TOVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TNXP: 89% vs. TOVX: 310%
Market capitalization -- TNXP: $296.28M vs. TOVX: $3.85M
TNXP [@Biotechnology] is valued at $296.28M. TOVX’s [@Biotechnology] market capitalization is $3.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TNXP’s FA Score shows that 2 FA rating(s) are green whileTOVX’s FA Score has 1 green FA rating(s).

  • TNXP’s FA Score: 2 green, 3 red.
  • TOVX’s FA Score: 1 green, 4 red.
According to our system of comparison, TNXP is a better buy in the long-term than TOVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TNXP’s TA Score shows that 3 TA indicator(s) are bullish while TOVX’s TA Score has 5 bullish TA indicator(s).

  • TNXP’s TA Score: 3 bullish, 4 bearish.
  • TOVX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TOVX is a better buy in the short-term than TNXP.

Price Growth

TNXP (@Biotechnology) experienced а +9.35% price change this week, while TOVX (@Biotechnology) price change was +9.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.40%. For the same industry, the average monthly price growth was +5.19%, and the average quarterly price growth was -2.05%.

Reported Earning Dates

TNXP is expected to report earnings on Aug 11, 2025.

TOVX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (+6.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNXP($296M) has a higher market cap than TOVX($3.85M). TNXP YTD gains are higher at: 22.650 vs. TOVX (-73.143). TOVX has higher annual earnings (EBITDA): -19.29M vs. TNXP (-76.74M). TNXP has more cash in the bank: 55M vs. TOVX (11.6M). TOVX has less debt than TNXP: TOVX (1.57M) vs TNXP (8.69M). TNXP has higher revenues than TOVX: TNXP (11.3M) vs TOVX (0).
TNXPTOVXTNXP / TOVX
Capitalization296M3.85M7,692%
EBITDA-76.74M-19.29M398%
Gain YTD22.650-73.143-31%
P/E Ratio0.11N/A-
Revenue11.3M0-
Total Cash55M11.6M474%
Total Debt8.69M1.57M555%
FUNDAMENTALS RATINGS
TNXP vs TOVX: Fundamental Ratings
TNXP
TOVX
OUTLOOK RATING
1..100
111
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9695
PRICE GROWTH RATING
1..100
3498
P/E GROWTH RATING
1..100
12100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TOVX's Valuation (9) in the null industry is in the same range as TNXP (28) in the Pharmaceuticals Other industry. This means that TOVX’s stock grew similarly to TNXP’s over the last 12 months.

TOVX's Profit vs Risk Rating (100) in the null industry is in the same range as TNXP (100) in the Pharmaceuticals Other industry. This means that TOVX’s stock grew similarly to TNXP’s over the last 12 months.

TOVX's SMR Rating (95) in the null industry is in the same range as TNXP (96) in the Pharmaceuticals Other industry. This means that TOVX’s stock grew similarly to TNXP’s over the last 12 months.

TNXP's Price Growth Rating (34) in the Pharmaceuticals Other industry is somewhat better than the same rating for TOVX (98) in the null industry. This means that TNXP’s stock grew somewhat faster than TOVX’s over the last 12 months.

TNXP's P/E Growth Rating (12) in the Pharmaceuticals Other industry is significantly better than the same rating for TOVX (100) in the null industry. This means that TNXP’s stock grew significantly faster than TOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TNXPTOVX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
TNXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLPPX9.870.02
+0.20%
LDR Real Estate Value Opportunity P
MMKBX22.54N/A
N/A
Morgan Stanley Inst Emerging Mkts A
PNOCX82.22N/A
N/A
Putnam Sustainable Leaders C
MSCRX10.37N/A
N/A
Madison Small Cap R6
FZABX29.50N/A
N/A
Fidelity Advisor Diversified Intl Z

TOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TOVX has been loosely correlated with GOVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TOVX jumps, then GOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TOVX
1D Price
Change %
TOVX100%
-3.81%
GOVX - TOVX
54%
Loosely correlated
+0.96%
VOR - TOVX
42%
Loosely correlated
-5.42%
TNXP - TOVX
35%
Loosely correlated
+6.28%
SER - TOVX
34%
Loosely correlated
-0.08%
REVB - TOVX
31%
Poorly correlated
+9.44%
More